-
Why are Non-Clinical Stakeholders Important to Medtech Companies?
Transcript: We have been thinking about this in terms of the personnel that a medtech manufacturer needs to interact with as far as commercializing a product goes. In the past we know physicians...
-
How are Medtech Companies Adapting to Better Engage with Non-Clinical Stakeholders?
Transcript: The spectrum of the types of services, programs, resources that hospitals need today is definitely changing as well as the type of stakeholders that are involved. So, when we use the term...
-
How are Non-Clinical Stakeholder Needs Expected to Change in the Future?
Transcript: When I think about the future, I think we have identified two things that are important to think about: the first one being how can medtech manufacturers partner with hospitals to help...
-
CAR T-Cell Therapy: Development Boom in China
CAR T-Cell Therapy: Development Boom in China China’s biotech innovation is challenging the dominance of the United States Healthcare reforms and strategies which encourage innovation and biotech...
-
Integrated Patient Journey: One Journey, Many Lenses
Integrated Patient Journey One Journey, Many Lenses Download our executive brief to learn: How the patient journey has evolved and what’s driving the need for a more comprehensive view The different...
-
Medtech Regulatory Dynamics 2020: 6 Big Regulatory Updates and Takeaways for Medtech Teams
2020 is expected to be a particularly eventful year for global medtech markets; be it due to brand new regulations, challenges to existing healthcare systems, updated trade agreements, unique...
-
CAR T-Cell Therapy: Engaging the Right Hospitals in Europe
CAR T-Cell Therapy: Engaging the Right Hospitals in Europe A Visual Guide to Locating Treatment Centers Growing from an estimated $172 million USD in 2020 to $1.35 billion USD by 2025 in major...
-
Type 2 Diabetes: Patient, Provider and Payer Trends and Planning Considerations
Find out which factors brands need to understand to get closer to their diabetes stakeholders and identify which activities have the greatest potential to impact outcomes. See below for patient,...
-
E-Books, Presentation, Webinars
Medtech Account Segmentation and Targeting Best Practices
Last year, there were over 900 healthcare merger and acquisition deals, transforming device purchasing dynamics and the level of influence across accounts and stakeholders. Today’s commercial teams...
-
What does Medtech need to know about the evolving role of the patient?
Hear what DRG Consultant, Paul O’Mahoney MD has to say about how patient interaction with healthcare is changing. Transcription: Yeah. So, what we're seeing now in the market is definitely an...
A global consultancy and training agency providing market leading product & portfolio strategy, health economic outcomes research & evidence generation, value communication and training services across the life science industry.
We partner with both the biopharmaceutical and medical technology industry to support commercialization & patient access across a variety of functions including: R&D, commercial strategy, HEOR, market access, new product planning, marketing, data insights & analytics, business development and channel & segment customer engagement.
